ABOUT THE FLOCK

As a member of the Market Access team (at bluebird, it’s Access, Value, and Evidence Strategy, “AVES”), you will be working alongside some of the most committed, creative, and experienced individuals in the cell and gene therapy industry to break new ground so that patients can access our FDA-approved gene therapies—patients who often have no therapeutic alternatives to battle progressive, debilitating, and life-shortening diseases. We are passionate about the science behind our gene therapies and the tremendous value we believe these one-time administered, potentially curative therapies bring to patients, their families, the healthcare system, and society overall. Everyone on our team has external-facing responsibilities, so we aim to be integrated and data- and evidence-driven to capitalize on the dynamic flow of information and insights across stakeholders (always being sure to maintain the highest standards of compliance). Join us if you too work best in a fast-paced and highly collaborative environment! 

HOW YOU’LL FLY

You'll help to bring more patients their bluebird days by: 

• Engaging regional commercial payers and State Medicaid Agencies to positively influence decision makers, policies, guidelines, and contracts to facilitate timely access to FDA-approved bluebird therapies.
• Maintaining, broadening, and deepening relationships on behalf of bluebird with target entities (e.g., payers, pharmacy, and medical benefits managers) that affect coverage and reimbursement decisions.
• Serving as the primary point-of-contact with bluebird’s Qualified Treatment Center network in the Midwest region for all market access-related issues, creating confidence in the access pathway for our therapies and coordinating and aggregating information and aligning AVES engagement strategy.
• Developing and maintaining core relationships with the business functions at bluebird’s QTCs. 
• Working cross-functionally, especially with the QTC account leads to pull through plans to mitigate and/or remove barriers to care at the consult and treatment phases of the patient journey. 
• Sharing insights and feedback from across market access stakeholders (with a focus on payers and financial decision makers at QTCs).
• Maintaining the utmost standards of professionalism and compliance in all internal and external engagements. 

WHAT YOU’LL BRING

You’re the bird we’re looking for if you have: 

• 10+ years of experience in the biotech/pharma field with a bachelor's degree required; master's degree in a relevant field (specifically finance) preferred.
• A track record of success engaging tertiary and quaternary clinical and research institutions and integrated delivery networks on market access issues.
• Experience specifically in the cell and gene therapy space and/or the rare disease space preferred; experience with product launches preferred. 
• Strong clinical aptitude / acumen.
• Deep knowledge of U.S. markets and understanding of Commercial PBMs / Payers and Government Payers.
• Demonstrated expertise as an SME for assigned key payer accounts with experience in navigating complex vertically integrated orgs.
• Experience negotiating and implementing outcomes-based or other alternative payment models preferred.

Compensation & Benefits 

We offer a total compensation and rewards package that ranks among the best in our industry. Base pay is one part of our total compensation package and is determined within a range. This provides the opportunity to progress as you grow and develop within a role. The anticipated annualized salary range for this role is $200,000 - $260,000. Your base pay will be determined based on several factors including market data, demonstrated skills, relevant education or training, experience, qualifications, internal equity, and travel requirements. Our overall package also includes eligibility for stock, incentive bonuses, and benefit programs, a flexible time off program, as well as paid holidays, bluebird days, and a holiday shutdown in December.